« August 2012 | Main | October 2012 »

4 posts from September 2012

09/21/2012

Medication Disposal and Drug Take Back Days

Failure to dispose of unused/unwanted medications, particularly controlled substances, presents a significant risk for drug diversion - theft from a medicine cabinet. Get rid of excess medications at the upcoming DEA Drug Take Back Day, scheduled for September 29th, 2012 from 10AM-2PM. See the website, www.deadiversion.usdoj.gov/drug_disposal/takeback/ for locations near you.

If you can't get there, at least follow these simple directions:
1. Mix medicines (do NOT crush tablets or capsules) with an unpalatable substance such as kitty litter or used coffee grounds;
2. Place the mixture in a container such as a sealed plastic bag; and
3. Throw the container in your household trash

For most medicines, DO NOT FLUSH them down the toilet. There are a few you can flush down the toilet - check with your pharmacist if yours is one of them.

09/14/2012

Sir George Alleyne, a speaker at our upcoming Lois K Cohen Lecture in Global Health, talks about the 1-year anniversary of the High Level UN meeting on noncommunicable diseases (NCDs) and the goal of reducing NCDs by 25% by year 2025. See here for more information about the upcoming lecture.

09/07/2012

Third Honey Festival a Fun Place for Science

The Philadelphia Beekeepers Guild is holding their third annual Honey Festival this weekend.  

The event will take place at three sites in the city of Philadelphia: Friday the Festival starts a Wagner Free Institute of Science, Saturday activities will take place at Wyck House and Bartram Gardens will host the Festival on Sunday.

You can start the weekend with Beekeeping 101.  Of course that’s just the start; there is much to do and to learn at the Festival.  To keep your energy up try some of the delicious foods made with honey. 

Saturday afternoon at Wyck House, a historical site in the Germantown neighborhood of Philadelphia, there will be three talks in the afternoon.   The presenters are Deborah Delaney, University of Delaware; Matthew Shoemaker and Sarah Newhouse, Historical Society of Pennsylvania; and Fred Schaefer, University of the Sciences.

For the USciences presentation Fred Schaefer, aka Sherlock "Honey" Holmes, will present some preliminary results from research being performed in collaboration with the Guild.  Co-authors Maria Christina Tettamanzi de Sproviero, Christine Rivera, and Tashnia Babar have used the techniques of gas chromatography/mass spectrometry and nuclear magnetic resonance spectroscopy to discern chemical differences in honeys from hives within the city of Philadelphia.

Sunday at Bartram Gardens, in West Philadelphia, there will be presentations by Stephanie Wilson, Morris Arboretum (University of Pennsylvania); Jessica Long, Pennsylvania Honey Queen; Jimmy McMillan, co-owner of Barry’s Home Brew; and Suzanne Matlock, of the Philadelphia Beekeepers Guild.

The website for the event is:

http://phillyhoneyfest.com/

09/04/2012

Accreditation of Community Pharmacies Can Have Important Benefits - But the Program Must Have Credibility and Value for the Participants!

By Dr. Daniel A. Hussar is the Remington Professor of Pharmacy at University of the Sciences' Philadelphia College of Pharmacy. He serves as the author and editor of The Pharmacist Activist newsletter (http://www.pharmacistactivist.com) from which this editorial was taken.

During the last several months two documents containing proposed accreditation standards for community pharmacies have been published with a request for public comment. The Center for Pharmacy Practice Accreditation (CPPA), a joint initiative by the American Pharmacists Association (APhA) and the National Association of Boards of Pharmacy (NABP), has developed "Draft Standards for Community Pharmacy Practice Accreditation," and invited public comment during the period June 30 - August 15, 2012. URAC, formerly known as the Utilization Review Accreditation Commission, has developed "Community Pharmacy Accreditation Proposed Standards," and invited public comment during the period July 6 - August 17, 2012.

The participation of a community pharmacy in an accreditation program would be voluntary.

Initial questions
With these announcements of accreditation programs, some questions come quickly to mind, including the following:

What is the intent of community pharmacy accreditation?
The materials provided by CPPA include frequently asked questions in which this is the first question that is addressed, in part, by the following response:

The program "…will be focused on accrediting community pharmacy practices to recognize quality, enhance patient safety and provide a mechanism for excellence-committed pharmacy practices to distinguish themselves.

A community pharmacy practice accreditation program may provide the means:

  • to ensure measurable, safe and effective patient care is being provided.
  • to empower pharmacists to practice at a higher level.
  • for a critical mass of pharmacy practices to achieve the JCPP 2015 Vision for Pharmacy Practice.
  • for pharmacy practice networks to recognize and provide consistent care to patients."

These are laudable goals, as is the JCPP 2015 Vision for Pharmacy Practice. Attainment of these goals will be of great benefit for individual patients, society, community pharmacists, and the profession of pharmacy. However, success in attaining these goals is dependent on the extent to which the accreditation program is recognized by community pharmacists as having value, the effectiveness with which the program is developed and implemented, and the credibility of the program both within and outside of the profession.

Are two community pharmacy accreditation programs necessary?
In a word, my response is an emphatic "No!" The most likely outcomes of having two programs are competition, confusion, and lack of credibility.

Who are the organizations and individuals who have proposed the accreditation programs?
URAC describes itself as a health care accreditation, education, and measurement organization with programs across the health care continuum. A pharmacist serves as a senior manager of product development and a pharmacist serves as chairman of the advisory group for the accreditation program. CPPA is a partnership between APhA and NABP, two long-established organizations within the profession.

I consider it very important that pharmacy accreditation programs, whether they be for community pharmacies, colleges of pharmacy, or other pharmacy initiatives, be developed and administered within the profession of pharmacy. Accordingly, it is my strong opinion that it is the CPPA initiative that should be supported by the profession of pharmacy. Not only is a second program, whether developed by URAC or another organization, not necessary, but it creates the potential for compromised validity and credibility for both programs. (In the interest of full disclosure, I am the Honorary President of APhA for the 2012-13 year but I was not a participant in the planning or decisions regarding the accreditation program.)

The pharmacists who have participated in the early phases of the accreditation initiatives include leaders from many areas of pharmacy practice. However, it is noteworthy how few of them own a pharmacy or otherwise practice in a community pharmacy on a full-time basis (nor do I as an individual offering opinions regarding this issue). The National Community Pharmacists Association (NCPA) is conspicuous by its absence as a partner in this accreditation initiative, a situation that is probably due to divided opinion among community pharmacists as to whether accreditation of their pharmacies will be of benefit.

In my opinion, the active support and participation of a large number of owners of independent pharmacies are essential if the community pharmacy accreditation program is to have validity and credibility.

Why is the comment period so brief and so lacking in opportunity for open discussions?
The scheduling of the comment period in both programs for such a short period of time (approximately 6 weeks) in the middle of summer is a mistake. I can only assume that this is a consequence of the competition between the two programs, and it represents an early indicator of the importance of not having more than one program. It is my impression that a large majority of community pharmacists and many leaders within the profession have not even seen the proposed standards and are not aware of the invitation to comment.

During the comment period identified, there was only one meeting held by a national pharmacy organization (American Association of Colleges of Pharmacy). A session was held to consider the proposed accreditation standards and the discussion was productive. However, the attendance was low because this was not a topic of high interest or priority for most of those at the meeting, and the session was held from 6:45 - 7:45 am. Open forums to discuss this topic should be held at meetings of organizations at which large numbers of community pharmacists will be in attendance. At the very least, such a forum should be included as part of NCPA's annual meeting in October.

Eligibility for accreditation
Although the proposed standards for accreditation of community pharmacies are specific and comprehensive, some important basic questions exist regarding the eligibility of a pharmacy to be considered for accreditation. I am assuming that a mail-order pharmacy would not be eligible for several reasons. First, it is not community-based but at a remote site. Secondly, the lack of personal face-to-face communication of pharmacists and patients precludes the provision of patient services that are inherent in certain of the practice standards. It is my understanding that URAC already has accreditation programs for mail-order pharmacies, suggesting that it makes a distinction between mail-order and community pharmacies.

Should a community pharmacy that sells tobacco products and/or alcoholic beverages be eligible for accreditation? My response is an emphatic "No!" A pharmacy that sells these products increases health risks for its patients in a manner that contradicts the intent of the proposed accreditation standards. The accreditation of such pharmacies would seriously compromise the credibility of the accreditation program. The response to one of the frequently asked questions in the materials provided for the CPPA program addresses the distinction between licensure and accreditation as follows:

"Licensure ensures minimal practice standards, while accreditation distinguishes a commitment to enhanced safety and improved quality of care delivered within the practice."


Accreditation suggests, if not requires, a commitment to the highest standard of safety for the patients served. The sale of tobacco products and/or alcoholic beverages must not be considered an acceptable activity for a pharmacy that wishes to have the distinction of being accredited.

At its June meeting, the American Medical Association (AMA) expanded its previous policy opposing the sale of tobacco products in pharmacies by adopting policy that would create a recognition program for pharmacies that voluntarily eliminate the sale of tobacco products. It would be a very unfortunate irony if pharmacy organizations somehow considered the sale of tobacco products to be compatible with accreditation at the same time the AMA is recognizing pharmacies that discontinue such.

Should an individual pharmacy in a large chain be eligible for accreditation if its parent company has policies/positions that increase risk for patients or demean the professional role of pharmacists? For example, should any CVS pharmacy be accredited when CVS/Caremark administers prescription benefit programs that steal patients from local pharmacies and fragment the care of patients, thereby placing them at increased risk of drug-related problems?

For many years, the profession of pharmacy has sought recognition for pharmacists as health care providers. However, in a recent situation, the management of Rite Aid took a position that essentially denied that pharmacists were health care providers. Fortunately, a Superior court judge, based on her determination that pharmacists are health care providers, ruled in favor of the plaintiff and against Rite Aid (Landay v. Rite Aid). To comply with the proposed accreditation standards, pharmacists fulfill responsibilities of a health care provider. Should any Rite Aid pharmacy be eligible for accreditation when its management does not even want its own pharmacists to be recognized as health care providers, and thereby places this recognition in jeopardy for all pharmacists?

Additional issues/recommendations
Numerous other important issues and questions exist, some of which are identified below:

  • Pharmacies must be accredited on an individual basis and not via accreditation of a parent organization (e.g., a large chain pharmacy).
  • The pharmacist manager of an accredited pharmacy must have the authority to make decisions that pertain to the ability to be in compliance with accreditation standards (e.g., professional services provided, level of professional staffing).
  • Many of the accreditation standards require policies, procedures, descriptions, documentation, etc. that will require, particularly for a small pharmacy, an extensive amount of time to develop and implement. Templates and "model" forms/documents should be developed (e.g., by CPPA, APhA, NCPA) to facilitate qualifying for accreditation and easing the administrative burden. The documentation of outcomes is very important but the highest priority must be given to the scope and quality of patient care services.
  • Notwithstanding the fact that pharmacy benefit managers (PBMs) do what they want to do and usually get away with it, the PBMs must not be permitted to reduce the size of their pharmacy networks by including only accredited pharmacies when the mail-order pharmacies they own and to which they direct patients do not meet the standards by which community pharmacies will be accredited.
  • The financial records of the accreditation program must be transparent.

The accreditation of community pharmacies has exciting potential to be a force for positive change and to accelerate the implementation of programs through which the actions and services of pharmacists enhance drug therapy outcomes for patients. However, it is imperative that the distinction of accreditation and the process through which it is earned are recognized to be of value and credible. This must start with the community pharmacists who are needed to be the participants, and whatever time and actions are necessary to obtain their enthusiastic participation are essential.
Daniel A. Hussar

© 2011 University of the Sciences in Philadelphia • 600 South 43rd Street • Philadelphia, PA 19104 • 215.596.8800